Free Trial

Hinge Health (HNGE) 10K Form and Latest SEC Filings 2026

Hinge Health logo
$62.80 +4.14 (+7.05%)
Closing price 03:59 PM Eastern
Extended Trading
$63.50 +0.70 (+1.12%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Hinge Health SEC Filings & Recent Activity

Hinge Health (NYSE:HNGE) has submitted 131+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Hinge Health's financial statements. The most recent filing was a Form 4 submitted on June 3, 2026.

Form 4
Hinge Health, Inc. Reports Ownership Change on Jun. 3, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Hinge Health Files Current Report on May. 5, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Hinge Health Files Quarterly Report on May. 7, 2026

The 10-Q contains Hinge Health's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Hinge Health SEC Filing History

Browse Hinge Health's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
06/03/2026 4:31 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:10 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:13 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 3:15 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2026 6:08 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2026 6:14 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2026 6:16 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:45 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2026 3:36 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2026 3:36 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2026 8:18 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2026 8:19 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 7:22 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:33 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 3:33 PM
Hinge Health (1673743) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 3:18 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 3:29 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2026 3:06 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2026 3:06 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 6:26 AM
HANSAINVEST Hanseatische Investment-Limited Co (1633724) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G
04/22/2026 3:16 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 7:13 AM
Hinge Health (1673743) Filer
Form DEFA14A
04/17/2026 7:17 AM
Hinge Health (1673743) Filer
Form ARS
04/17/2026 7:04 AM
Hinge Health (1673743) Filer
Form DEF 14A
04/07/2026 3:46 PM
Hinge Health (1673743) Issuer
Sloat Tyler (1735436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:07 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:23 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:24 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 8:30 AM
Hinge Health (1673743) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/24/2026 6:35 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 6:37 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 3:34 PM
Hinge Health (1673743) Subject
Pursley James (1783108) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/23/2026 3:35 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2026 3:22 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2026 7:50 PM
Atomico Advisors IV, Ltd. (2069654) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
03/06/2026 3:32 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 4:25 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2026 6:12 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 5:42 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 3:15 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 8:34 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Filed by
Form SCHEDULE 13G/A
Trump’s secret China deal (Ad)

Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all.tc pixel

Watch the full documentary and see which assets are positioned to benefit
02/13/2026 5:10 PM
ALKEON CAPITAL MANAGEMENT LLC (1230239) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
02/13/2026 4:25 PM
Hinge Health (1673743) Subject
Insight Holdings Group, LLC (1305473) Filed by
Form SCHEDULE 13G/A
02/03/2026 7:44 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 7:45 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2026 6:18 AM
HANSAINVEST Hanseatische Investment-Limited Co (1633724) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G
01/06/2026 3:58 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 3:37 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 3:33 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 3:34 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:18 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:17 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 3:24 PM
Hinge Health (1673743) Subject
Pursley James (1783108) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2025 3:22 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2025 4:59 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 3:51 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2025 3:07 PM
Hinge Health (1673743) Subject
JANE STREET GROUP, LLC (1595888) Filed by
Form SCHEDULE 13G
12/12/2025 5:02 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 5:03 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 3:37 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2025 3:06 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2025 3:07 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 8:20 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2025 6:37 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2025 4:22 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 4:19 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 4:20 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 4:21 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2025 12:21 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2025 12:21 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 3:28 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 3:30 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2025 7:06 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 3:28 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 3:27 PM
Hinge Health (1673743) Issuer
Leslie Kristina M (1307207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 4:57 PM
Hinge Health (1673743) Subject
Leslie Kristina M (1307207) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 3:45 PM
Hinge Health (1673743) Subject
Pursley James (1783108) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 3:10 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 5:54 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 5:55 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Bessemer Venture Partners X L.P. (1768640) Reporting
Deer X & Co. L.P. (1768637) Reporting
Deer X & Co. Ltd. (1768677) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:23 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:51 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:52 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:54 PM
Hinge Health (1673743) Issuer
Leslie Kristina M (1307207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:01 PM
Hinge Health (1673743) Subject
Leslie Kristina M (1307207) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 3:49 PM
Hinge Health (1673743) Subject
Leslie Kristina M (1307207) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 3:55 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 3:56 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 7:02 PM
Alyeska Investment Group, L.P. (1453072) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
11/12/2025 8:05 AM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2025 3:07 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
09/25/2025 5:43 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025 4:37 PM
Alyeska Investment Group, L.P. (1453072) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G
08/14/2025 3:35 PM
Hinge Health (1673743) Subject
Insight Holdings Group, LLC (1305473) Filed by
Form SCHEDULE 13G
08/14/2025 3:11 PM
11.2 Capital I, L.P. (1591336) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G
08/13/2025 6:02 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Filed by
Form SCHEDULE 13G
08/13/2025 6:03 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Filed by
Form SCHEDULE 13G
08/13/2025 5:30 AM
ALKEON CAPITAL MANAGEMENT LLC (1230239) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G
08/11/2025 3:19 PM
Hinge Health (1673743) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Hinge Health SEC Filings - Frequently Asked Questions

Hinge Health (HNGE) has submitted 131+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

Hinge Health's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Hinge Health's financial statements page.

The most recent filing was a Form 4 submitted on June 3, 2026. This was an insider ownership change filed by 4 - Hinge Health, Inc. (0001673743) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:HNGE) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners